Increased caveolin-1 expression associated with prolonged overall survival rate in hepatocellular carcinoma

References

• Parton RG, Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol 2007; 8: 185–194.
   PubMed Web of Science ®Google Scholar
• Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 2005; 288: C494–C506.
   PubMed Web of Science ®Google Scholar
• Cohen AW, Hnasko R, Schubert W, et al Role of caveolae and caveolins in health and disease. Physiol Rev 2004; 84: 1341–1379.
   PubMed Web of Science ®Google Scholar
• Shaul PW, Anderson RG. Role of plasmalemmal caveolae in signal transduction. Am J Physiol 1998; 275: L843–L851.
   PubMedGoogle Scholar
• Stan RV. Structure of caveolae. Biochim Biophys Acta 2005; 1746: 334–348.
   PubMed Web of Science ®Google Scholar
• Le Lay S, Kurzchalia TV. Getting rid of caveolins: phenotypes of caveolin-deficient animals. Biochim Biophys Acta 2005; 1746: 322–333.
   PubMedGoogle Scholar
• Schwencke C, Braun-Dullaeus RC, Wunderlich C, et al Caveolae and caveolin in transmembrane signaling: Implications for human disease. Cardiovasc Res 2006; 70: 42–49.
   PubMed Web of Science ®Google Scholar
• Williams TM, Medina F, Badano I, et al Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 2004; 279: 51630–51646.
   PubMed Web of Science ®Google Scholar
• Frank PG, Lisanti MP. Caveolin-1 and liver regeneration: role in proliferation and lipogenesis. Cell Cycle 2007; 6: 115–116.
   PubMed Web of Science ®Google Scholar
• Yokomori H, Oda M, Yoshimura K, et al Elevated expression of caveolin-1 at protein and mRNA level in human cirrhotic liver: relation with nitric oxide. J Gastroenterol 2003; 38: 854–860.
   PubMedGoogle Scholar
• Schubert W, Frank PG, Woodman SE, et al Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. J Biol Chem 2002; 38: 40091–40098.
   Google Scholar
• Bucci M, Gratton JP, Rudic RD, et al In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 2000; 6: 1362–1367.
   PubMed Web of Science ®Google Scholar
• Rao CV. Nitric oxide signaling in colon cancer chemoprevention. Mutat Res 2004; 555: 107–119.
   PubMed Web of Science ®Google Scholar
• Zhang W, Kuncewicz T, Yu ZY, et al Protein-protein interactions involving inducible nitric oxide synthase. Acta Physiol Scand 2003; 179: 137–142.
   PubMedGoogle Scholar
• Ziche M, Morbidelli L, Masini E, et al Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94: 2036–2044.
   PubMed Web of Science ®Google Scholar
• Leibovich SJ, Polverini PJ, Fong TW, et al Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci USA 1994; 91: 4190–4194.
   PubMed Web of Science ®Google Scholar
• Jenkins DC, Charles IG, Thomsen LL, et al Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995; 92: 4392–4396.
   PubMed Web of Science ®Google Scholar
• Lim KH, Ancrile BB, Kashatus DF, et al Tumour maintenance is mediated by eNOS. Nature 2008; 452: 646–649.
   PubMed Web of Science ®Google Scholar
• Decker NK, Abdelmoneim SS, Yaqoob U, et al Nitric oxide regulates tumor cell cross-talk with stromal cells in the tumor microenvironment of the liver. Am J Pathol 2008; 173: 1002–1012.
   PubMedGoogle Scholar
• Yokomori H, Oda M, Ogi M, et al Enhanced expression of endothelial nitric oxide synthase and caveolin-1 in human cirrhosis. Liver 2002; 22: 150–158.
   PubMedGoogle Scholar
• Scheuer PJ, Davies SE, Dhillon AP. Histopathological aspects of viral hepatitis. J Viral Hepat 1996; 3: 277–283.
   PubMedGoogle Scholar
• Yeh YT, Ou-Yang F, Chen IF, et al Altered p-JAK1 expression is associated with estrogen receptor status in breast infiltrating ductal carcinoma. Oncol Rep 2007; 17: 35–39.
   Google Scholar
• Wang SN, Yeh YT, Yang SF, et al Potential role of leptin expression in hepatocellular carcinoma. J Clin Pathol 2006; 59: 930–934.
   PubMedGoogle Scholar
• Massion PB, Dessy C, Desjardins F, et al Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation 2004; 110: 2666–2672.
   PubMedGoogle Scholar
• Yuan SS, Cox LA, Dasika GK, et al Cloning and functional studies of a novel gene aberrantly expressed in RB-deficient embryos. Dev Biol 1999; 207: 62–75.
   PubMedGoogle Scholar
• Wang SN, Yeh YT, Yu ML, et al Serum adiponectin levels in cholesterol and pigment cholelithiasis. Br J Surg 2006; 93: 981–986.
   PubMedGoogle Scholar
• Yang SF, Wang SN, Wu CF, et al Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma. J Clin Pathol 2007; 60: 642–648.
   PubMed Web of Science ®Google Scholar
• Meye C, Schumann J, Wagner A, et al Effects of homocysteine on the levels of caveolin-1 and eNOS in caveolae of human coronary artery endothelial cells. Atherosclerosis 2007; 190: 256–263.
   PubMedGoogle Scholar
• Felley-Bosco E, Bender F, Quest AF. Caveolin-1-mediated post-transcriptional regulation of inducible nitric oxide synthase in human colon carcinoma cells. Biol Res 2002; 35: 169–176.
   PubMedGoogle Scholar
• Yokomori H, Oda M, Ogi M, et al Endothelial nitric oxide synthase and caveolin-1 are co-localized in sinusoidal endothelial fenestrae. Liver 2001; 21: 198–206.
   PubMedGoogle Scholar
• Van den Eynden GG, Van Laere SJ, Van der Auwera I, et al Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Res Treat 2006; 95: 219–228.
   PubMed Web of Science ®Google Scholar
• Chen ST, Lin SY, Yeh KT, et al Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers. Int J Mol Med 2004; 14: 577–582.
   PubMedGoogle Scholar
• Wikman H, Seppanen JK, Sarhadi VK, et al Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays. J Pathol 2004; 203: 584–593.
   PubMedGoogle Scholar
• Erdamar S, Bagci P, Oz B, et al Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors. J BUON 2006; 11: 213–216.
   PubMedGoogle Scholar